FEATURE Regulatory compliance
Ensuring ICH compliance for pharmaceuticals
T
he pharmaceutical industry operates within a complex and highly regulated environment, where ensuring the quality,
paramount. The International Council for Harmonisation (ICH) develops guidelines that standardise key processes related to drug development and manufacturing industry experts.
The ICH guidelines are grouped into four main categories: Quality (Q-series), and Multidisciplinary (M-series). The guidelines in the Q-series ensure the quality of medicines at all stages of development, from initial design through to manufacturing. Key elements of this series include Good Manufacturing Practices (GMP), risk management, and continuous improvement. The Safety (S-series) guidelines focus on minimising risks to patient health, particularly during preclinical development. They cover areas such as carcinogenicity, genotoxicity, and reprotoxicity.
sure that clinical trials and therapeutic evaluations are robust and provide reliable Finally, Multidisciplinary Guidelines (M-series) cover cross-functional areas such as electronic submissions (eCTD) and the use of medical terminology (MedDRA) for regulatory documentation. Supporting quality assurance with
zenon Adhering to all facets of these guidelines
high-quality medicines are developed support for pharmaceutical companies to do so. zenon, from COPA-DATA, provides manufacturers with tools to meet complex regulatory demands within the industry while optimising production processes data integrity, and supporting quality management.
In line with Q-series guidelines, zenon can provide valuable assistance to
10 November 2024 | Automation
Stephan Nobis, Business Development Manager at COPA- DATA, explains how software solutions help ensure adherence to the International Council for Harmonisation (ICH) guidelines
companies seeking in particular to comply with ICH guidelines.
ICH Q7: Adhering to Good
Manufacturing Practices (GMP) for APIs For example, ICH Q7 is focused on Good Manufacturing Practices for Active Pharmaceutical Ingredients (APIs), ensuring that they meet stringent quality and purity requirements. zenon helps companies adhere to these GMP guidelines by visualising and managing operational process data in real-time. This real-time monitoring allows for immediate detection of GMP deviations, triggering alerts to the appropriate quality assurance (QA) personnel for quick intervention. Through zenon’s comprehensive electronic batch records, pharmaceutical companies can minimise batch release times, ensuring that products meet regulatory standards without delay. Key features like user management, eSignature, audit trails, and deviation detection help to implement GMP- compliant projects seamlessly. These tools ensure that regulatory mistakes are minimised, and product quality is maintained consistently. Moreover, zenon’s connectivity to over 300 hardware protocols integrates with existing manufacturing systems, ensuring ICH Q8: Supporting Quality by Design
(QbD)
ICH Q8 focuses on the implementation of Quality by Design (QbD), a systematic approach that emphasises product and process understanding to ensure consistent
quality. zenon facilitates QbD by enabling pharmaceutical companies to collect and analyse vast amounts of process data and the production lifecycle. With zenon’s historian, real-time data collection, and analysis tools, companies can make data- driven decisions that optimise process parameters, ensuring that products are parameters. By continuously monitoring key process variables and utilising zenon’s recipe management tools, manufacturers maintain product quality.
In today’s pharmaceutical industry, ensuring compliance with international guidelines like those from the ICH is critical. The zenon software platform pharmaceutical companies in meeting the ICH guidelines and can assist in the areas of GMP compliance, QbD, and lifecycle management.
By integrating automation, real-time data collection, and process optimisation into their operations, pharmaceutical companies can not only ensure compliance but also enhance productivity and product pharmaceutical companies striving for compliance in a highly regulated and competitive market, preserving both data integrity and the quality of medicines for global patients.
COPA-DATA
www.copadata.com
automationmagazine.co.uk
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48
